GSK plc's stock price has significantly outperformed the healthcare sector this year, supported by its healthy Q1 2025 ...

GSK will use AI, dual sourcing to offset tariff hit Q1 results better-than-expected Shares up 3.8% Maintains 2025 turnover and profit forecasts April 30 (Reuters) - GSK (GSK.L), opens new tab on ...

Uncertainty continues to hang over the latest round of financial results and forecasts for companies both big and small as ...

GSK Plc reported better-than-expected profit in the first quarter as sales from its asthma and HIV drugs offset a lackluster vaccine performance. The UK drugmaker’s shares surged after it ...

As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the British drug giant feels prepared for any challenges that U.S. drug import ...

(Reuters) - GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts and dual sourcing for its medicines, but offered few details.

GSK is 'well positioned' to deal with the potential implications of any new US tariffs on pharma imports, the group said on Wednesday. President Donald Trump slapped a 10 per cent baseline ...

Royalty Income for 2025: Expected to be GBP 750 to 800 million. GSK PLC (NYSE:GSK) reported a 4% increase in group sales and a 5% rise in operating profit, demonstrating the strength and resilience of ...

NEW YORK — Uncertainty continues to hang over the latest round of financial results and forecasts for companies both big and small as they ... U.K.-based drugmaker GSK, formerly known as ...

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. GSK has three segments: Specialty Medicines (HIV, Oncology, Immunology/Respiratory and Other), Vaccines ...